ARCHIVE OF OLDER REPORTS AND DEVELOPMENTS
(Before March 2001)

MARCH 2001:

  Human Genome Sciences To Test New Delivery Method for HCV Interferon
     By Scott Henley of the Wall St. Journal / Help
(3/25/2001) 

  New HCV Treatment in Phase I
Human Genome Sciences Begins Phase I Clinical Trial of Albuferon in Hepatitis C Patients -- First Albumin Fusion Protein Trial
(3/23/2001)

  Recurrence of CMV Despite CD4 Reconstitution
Recurrences of Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-Infected Patient, Despite Potent Antiretroviral Therapy and Apparent Immune Reconstitution
(3/22/2001)

   Cervical Inflammation Dramatically Increases HIV-1 Shedding - avoid sexual intercourse for 4 weeks after treatment of cervical lesions
(3/22/2001)

   Investigator Sites for Protocol #T20-301/NV16054
...arranged by State
   with...
   T-20: list of study sites for phase 3 study for patients with resistant virus
Full report in PDF version only
(3/11/2001)

   Check Your Thyroid Function Before & During Interferon Therapy: Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences
(3/11/2001)

   New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys
NIAID Office of Communications and Public Liaison
(3/11/2001)

  Worrisome Trends in Transmission of Drug Resistant Virus:
14% of newly infected patients have Resistance Before Therapy & This Can Reduce Response to Therapy
(3/11/2001)

 This Study Reports Cancer Can Develop in Small Number of Sustained Virologic Responders to HCV Therapy
    Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C
(3/01/2001)